[go: up one dir, main page]

ITMI920393A0 - STEROID FORMULATIONS - Google Patents

STEROID FORMULATIONS

Info

Publication number
ITMI920393A0
ITMI920393A0 IT92MI393A ITMI920393A ITMI920393A0 IT MI920393 A0 ITMI920393 A0 IT MI920393A0 IT 92MI393 A IT92MI393 A IT 92MI393A IT MI920393 A ITMI920393 A IT MI920393A IT MI920393 A0 ITMI920393 A0 IT MI920393A0
Authority
IT
Italy
Prior art keywords
steroid formulations
steroid
formulations
Prior art date
Application number
IT92MI393A
Other languages
Italian (it)
Inventor
Joy Elaine Saunders
Original Assignee
Fisons
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fisons filed Critical Fisons
Publication of ITMI920393A0 publication Critical patent/ITMI920393A0/en
Publication of ITMI920393A1 publication Critical patent/ITMI920393A1/en
Application granted granted Critical
Publication of IT1254627B publication Critical patent/IT1254627B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
ITMI920393A 1991-02-23 1992-02-21 Steroid formulations IT1254627B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919103824A GB9103824D0 (en) 1991-02-23 1991-02-23 Formulation
PCT/GB1992/000290 WO1992014473A1 (en) 1991-02-23 1992-02-19 Steroid formulations

Publications (3)

Publication Number Publication Date
ITMI920393A0 true ITMI920393A0 (en) 1992-02-21
ITMI920393A1 ITMI920393A1 (en) 1993-08-21
IT1254627B IT1254627B (en) 1995-09-28

Family

ID=10690478

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI920393A IT1254627B (en) 1991-02-23 1992-02-21 Steroid formulations

Country Status (13)

Country Link
CN (1) CN1065010A (en)
AU (1) AU1247192A (en)
BE (1) BE1004177A4 (en)
FR (1) FR2673104A1 (en)
GB (1) GB9103824D0 (en)
GR (1) GR1001511B (en)
IE (1) IE920516A1 (en)
IL (1) IL101010A0 (en)
IT (1) IT1254627B (en)
MX (1) MX9200748A (en)
PT (1) PT100150A (en)
WO (1) WO1992014473A1 (en)
ZA (1) ZA921247B (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0551626A1 (en) * 1991-12-19 1993-07-21 LEK, tovarna farmacevtskih in kemicnih izdelkov, d.d. Thermoreversible gel as a liquid pharmaceutical carrier for a galenic formulation
US5976573A (en) * 1996-07-03 1999-11-02 Rorer Pharmaceutical Products Inc. Aqueous-based pharmaceutical composition
JP2005281315A (en) * 1997-07-02 2005-10-13 Aventis Pharmaceuticals Holdings Inc Aqueous pharmacological composition
TWI243687B (en) 1998-04-21 2005-11-21 Teijin Ltd Pharmaceutical composition for application to mucosa
US20030059440A1 (en) * 1998-09-01 2003-03-27 Tim Clarot Composition and method for moisturizing nasal tissue
AR026072A1 (en) * 1999-10-20 2002-12-26 Nycomed Gmbh PHARMACEUTICAL COMPOSITION CONTAINING CICLESONIDE FOR MUCOSA APPLICATION
AR026073A1 (en) 1999-10-20 2002-12-26 Nycomed Gmbh PHARMACEUTICAL COMPOSITION AQUATIC CONTAINING CICLESONIDE
DE10064950A1 (en) * 2000-12-23 2002-07-11 Impetus Ag Basel Thixotropic nasal spray
EP1645266A1 (en) * 2004-10-08 2006-04-12 Hisamitsu Medical Co., Ltd. Aqueous suspension for nasal drops
EP2057982A1 (en) * 2007-11-09 2009-05-13 Archimedes Development Limited Intranasal compositions
WO2013049539A1 (en) * 2011-09-30 2013-04-04 Mcneil-Ppc, Inc. A method of blocking or trapping allergens
WO2019073298A1 (en) * 2017-10-11 2019-04-18 Lifescience As NEURAMINIC ACID COMPOSITIONS AND METHODS OF USE
AU2020220560A1 (en) * 2019-02-11 2021-09-02 Reckitt Benckiser Health Limited Novel composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4361559A (en) * 1981-08-20 1982-11-30 E. R. Squibb & Sons, Inc. Antiinflammatory 17,17-bis (substituted thio) androstenes
US4782047A (en) * 1986-05-22 1988-11-01 Syntex Pharmaceuticals International Ltd. Aqueous steroid formulations for nasal administration
US4868170A (en) * 1987-11-13 1989-09-19 E. R. Squibb & Sons, Inc. Steriod lotion formulation
IL97065A (en) * 1990-02-02 1994-01-25 Fisons Plc Aerosol propellant compositions

Also Published As

Publication number Publication date
IT1254627B (en) 1995-09-28
BE1004177A4 (en) 1992-10-06
CN1065010A (en) 1992-10-07
IE920516A1 (en) 1992-08-26
ITMI920393A1 (en) 1993-08-21
AU1247192A (en) 1992-09-15
MX9200748A (en) 1992-10-01
ZA921247B (en) 1992-10-28
WO1992014473A1 (en) 1992-09-03
FR2673104A1 (en) 1992-08-28
GB9103824D0 (en) 1991-04-10
IL101010A0 (en) 1992-11-15
GR1001511B (en) 1994-02-28
PT100150A (en) 1993-05-31

Similar Documents

Publication Publication Date Title
NO934009D0 (en) PHARMASOEYTIC FORMULATIONS
NO920987D0 (en) PHARMASOEYTICAL AEROSOL FORMULATIONS
FI933122L (en) FOERBAETTRAD HERBICIDISK FORMULATION
FI924669A7 (en) Anti-lice formulations
FI933655L (en) REDUCED POLYDEXTROS
FI922030L (en) LOW CALORICHOKLAD
MA22220A1 (en) GELLIED FORMULATIONS
FI933450A7 (en) New steroids
FI933363L (en) 17-SPIROMETHYLENE STEROID
FI950402A7 (en) Oral formulations
FI922270L (en) DILTIAZEMI FORMULATION
FI924305L (en) N-ALKYL-3-PHENYL-3-(2-ALKYLTHIOPHENOX)PROPYLAMINER
FI933467L (en) COMPOSITION
FI924643A7 (en) BRAENSLE COMPOSITION
ITMI920393A0 (en) STEROID FORMULATIONS
FI922681L (en) NOW FOERPACKNINGS/BEHAOLLARSYSTEM
ATA11391A (en) FITTING
FI934710A0 (en) 4-Aryl-3- (HETEROARYLUREIDO) KINOLINDERIVAT
FI924670A7 (en) Anti-lice formulations
MX9204183A (en) PROSTAGLADINE E1 FORMULATION
FI934447A0 (en) NOW IMMUNHAEMMANDE AEMNE FRAON STRPTOMYCES BRAEGENSIS
FI922683L (en) NOW FOERPACKNINGS/BEHAOLLARSYSTEM
FI925827L (en) TVAERBINDBAR POLYMERISK COMPOSITION
DK0718273T3 (en) Ethyl 6-formyloxy-4-hexenoate
DE69225266D1 (en) Bis-bibenzimidazole composition

Legal Events

Date Code Title Description
0001 Granted